Risk-managed antidepressant prescribing in primary care mental health: what pharmacogenetics can (and cannot) deliver
Frontiers in Medicine · 15.04.2026 · 13
DOI: 10.3389/fmed.2026.1814980 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Medicine, online erschienen am 15.04.2026. Verfasst von Waseem Jerjes und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Primary Care and Public Health, Faculty of Medicine, Imperial College London, London, United Kingdom. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Primary Care and Public Health, Faculty of Medicine, Imperial College London, London, United Kingdom.
- North End Medical Centre, Hammersmith and Fulham Primary Care Network, London, United Kingdom.
Zitieren
APA
Jerjes, W., Harding, D., & Klingbajl, M. (2026). Risk-managed antidepressant prescribing in primary care mental health: what pharmacogenetics can (and cannot) deliver. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1814980
Vancouver
Jerjes W, Harding D, Klingbajl M. Risk-managed antidepressant prescribing in primary care mental health: what pharmacogenetics can (and cannot) deliver. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1814980
BibTeX
@article{Jerjes2026,
author = {Jerjes, Waseem and Harding, Daniel and Klingbajl, Marcin},
title = {Risk-managed antidepressant prescribing in primary care mental health: what pharmacogenetics can (and cannot) deliver},
journal = {Frontiers in Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fmed.2026.1814980}
}
EUVIMED